US EditionBristlecone Advisors LLC Boosts Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bristlecone Advisors LLC Boosts Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Bristlecone Advisors LLC grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 4.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,250 shares of the pharmaceutical company’s stock after buying an additional 100 shares during the quarter. Bristlecone Advisors LLC’s […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
